Gasco Isopropyl Alcohol 70% recall — Gasco Industrial Corp. (Class II)
Gasco Industrial Corp. is recorded by the U.S. Food and Drug Administration (FDA) as recalling Gasco Isopropyl Alcohol 70% — a Class II recall, initiated 2026-05-29 and posted to the FDA enforcement report on 2026-07-15, under recall number D-0667-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Subpotent drug”. From the product description, the strengths given are 70% and 946 mL. The record carries UPC 787302123636 rather than an NDC. Distribution is recorded as “Nationwide within the US” — Nationwide (US), with the recalling firm on record in PR, United States. The FDA files it under event ID 99138 together with 5 other recall numbers, all listed and linked below. Within that event this is the strength 70% · 946 mL and product named Gasco Isopropyl Alcohol 70% configuration; the sibling records differ on strength and product named and match on everything else the source states. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0667-2026 |
|---|---|
| FDA event ID | 99138 (6 recall numbers) |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Gasco Industrial Corp. |
| Recall initiated | 2026-05-29 |
| Reported by FDA | 2026-07-15 |
| Report lag | 47 days from initiation to report |
| Distribution | Nationwide within the US — Nationwide (US) |
| Firm location on record | PR, United States |
| Product description (source) | Gasco Isopropyl Alcohol 70%, 32 oz (946 mL) Gasco Industrial Corp., PO Box 1360, Gurabo PR 00778, UPC 7 87302 12363 6. |
Reason reported by FDA
Subpotent drug
2 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
3 identifying values matched by exact pattern in the 22-word product description above; each is a literal substring of it.
| Product named | Gasco Isopropyl Alcohol 70% |
|---|---|
| Strength | 70% · 946 mL |
| UPC | 787302123636 |
Which configuration this record is
6 recall numbers share event 99138. They differ on strength and product named and agree on everything else the source states, so those are the values to check a package against.
| Attribute | This record (D-0667-2026) | D-0665-2026 | D-0666-2026 | D-0668-2026 | D-0669-2026 | D-0670-2026 |
|---|---|---|---|---|---|---|
| Strength | 70% · 946 mL | 70% · 474 mL · 1360 G | 70% · 3.78 L | 70% · 1 g · 3.78 l | 70% · 474 mL | 70% · 946 mL |
| Product named | Gasco Isopropyl Alcohol 70% | Gasco Isopropyl Alcohol 70% | Gasco Isopropyl Alcohol 70% | Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% |
Shared across all 6 records under this event: fda tier Class II; recalling firm Gasco Industrial Corp.; reason text Subpotent drug; initiated 2026-05-29; reported 2026-07-15.
Event context: 6 recall numbers under event 99138
One enforcement action, 6 recall numbers: the FDA filed 5 further configurations of this action under event 99138. Each keeps its own recall number and dates.
| Recall record | Recall number | FDA tier | Strength / form | Reported |
|---|---|---|---|---|
| Gasco Isopropyl Alcohol 70% | D-0665-2026 | Class II | 70% | 2026-07-15 |
| Gasco Isopropyl Alcohol 70% | D-0666-2026 | Class II | 70% | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0668-2026 | Class II | 70% | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0669-2026 | Class II | 70% | 2026-07-15 |
| Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% | D-0670-2026 | Class II | 70% | 2026-07-15 |
Reported in the same month (2026-07)
111 enforcement reports carry a report date in 2026-07; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Methohexital Sodium for Injection, 500 mg | D-0662-2026 | Onesource Specialty Pharma Ltd | Class II | 2026-07-15 |
| Medline Remedy Specialized Silicone Cream (Hydraguard-D ), 59 mL | D-0663-2026 | Biomed Laboratories, Llc. | Class II | 2026-07-15 |
| Methohexital Sodium, 100 mg/10 mL | D-0664-2026 | Quva Pharma, Inc. | Class II | 2026-07-15 |
| Pemetrexed for Injection 100mg/Vial | D-0671-2026 | Reliance Life Sciences Private Ltd | Class II | 2026-07-15 |
| Pemetrexed for Injection 500mg/Vial | D-0672-2026 | Reliance Life Sciences Private Ltd | Class II | 2026-07-15 |
| Bortezomib for Injection 3.5mg/Vial | D-0673-2026 | Reliance Life Sciences Private Ltd | Class II | 2026-07-15 |
| Azacitidine for Injection 100mg/Vial | D-0674-2026 | Reliance Life Sciences Private Ltd | Class II | 2026-07-15 |
| Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG | D-0691-2026 | Shimoga Chemicals | Class II | 2026-07-15 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 3 nearest to 2026-07-15 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| BD ChloraPrep Hi-Lite Orange, 2% | D-0643-2026 | Carefusion 213, LLC | 2% · Solution | 2026-07-08 |
| BD PurPrep, 8.3% | D-0644-2026 | Carefusion 213, LLC | 8.3% · Solution | 2026-07-08 |
| BD ChloraPrep Clear, 2% | D-0645-2026 | Carefusion 213, LLC | 2% · Solution | 2026-07-08 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. A search on event 99138 returns all 6 of these recall numbers; a search on D-0667-2026 returns only this configuration. This record identifies packages by UPC 787302123636 rather than by NDC.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Gasco Industrial Corp. (6 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0667-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0667-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-07-15
- Ingested
- 2026-08-22
- Record hash
fccb19b191512703
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.